Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Syneos Health Inc SYNH

Technology Scientific & Technical Instruments
Syneos Health, Inc. is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services. The Company operates through two business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The Clinical Solutions segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions (public relations, advertising, and medical communications), and consulting services. The Company’s customers include small, mid-sized, and large companies in the biopharmaceutical, biotechnology, and medical device industries.


NDAQ:SYNH - Post by User

Syneos Health Inc
Bullboard Posts
User Avatar Image
(137)
•••
Post by DavidRosenbergon Jul 18, 2023 7:57am
42 Views
Post# 35545554

$SYNH $ HUGE unable to recruit scam

$SYNH $ HUGE unable to recruit scam Incompetence by Syneos health

 FSD Pharma is looking  to get in touch with companies who are in a similar situation with Syneos health seems like these incompetent "contract research organizations" scam small biotechs with no patients tested yet tout they are professional 

they couldn't recruit any patients yet kept billing fsd Pharma by the way im a fsd Pharma investor and I'm pissed at this that's why I'm posting this for all to see !!!

Syneos was unable to recruit patients yet kept billing fsd Pharma !!!! What's up with that 


https://financialpost.com/pmn/business-wire-news-releases-pmn/arbitration-panel-finds-that-syneos-health-nasdaq-synh-failed-to-use-commercially-reasonable-efforts-in-conducting-its-trial-for-fsd-201





Bullboard Posts
Dealroom for high-potential pre-IPO opportunities